Can we improve patient outcomes through using evidence-based opioid deprescribing guidelines to reduce opioid use?

Pain. 2022 Feb 1;163(2):e382. doi: 10.1097/j.pain.0000000000002371.

Authors

Aili V Langford¹, Carl R Schneider¹, Chung-Wei Christine Lin², Danijela Gnjidic¹

Affiliations

¹ Faculty of Medicine and Health, School of Pharmacy, The University of Sydney, Sydney, New South Wales, Australia.
² Institute for Musculoskeletal Health, Faculty of Medicine and Health, School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.

PMID: 35029601
DOI: 10.1097/j.pain.0000000000002371

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Analgesics, Opioid / therapeutic use
Deprescriptions*
Humans
Opioid-Related Disorders* / drug therapy
Opioid-Related Disorders* / prevention & control

Substances

Analgesics, Opioid